A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: Role of ERCC1 expression. | |
Huang, Jing; Zhou, Yi; Qu, Tao; Zhang, Hong-Tu; Mao, You-Sheng; Zhu, Hong-Xia; Quan, Lan-Ping; Xing, Pu-Yuan; Wang, Jin-Wan; Jie, He | |
2012 | |
会议名称 | JOURNAL OF CLINICAL ONCOLOGY |
会议日期 | 2012-05-20 |
收录类别 | CPCI-S |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6707023 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Huang, Jing,Zhou, Yi,Qu, Tao,et al. A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: Role of ERCC1 expression.[C]. 见:JOURNAL OF CLINICAL ONCOLOGY. 2012-05-20. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论